Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
AIM: To identify the barriers and facilitators to start insulin in patients with type 2 diabetes. METHOD: This was a systematic review. We conducted a systematic search using PubMed, EMBASE, CINAHL and Web of Science (up to 5 June 2014) for original English articles using the terms 'type 2 diabetes', 'insulin', and free texts: 'barrier' or 'facilitate' and 'initiate'. Two pairs of reviewers independently assessed and extracted the data. Study quality was assessed with Qualsyst. RESULTS: A total of 9740 references were identified: 41 full-text articles were assessed for eligibility. Twenty-five articles (15 qualitative, 10 quantitative) were included in the review. Good inter-rater reliability was observed for the Qualsyst score (weighted kappa 0.7). Three main themes identified were as follows: patient-related, healthcare professional and system factors. The main patient-related barriers were fear of pain and injection (n = 18), concerns about side effects of insulin (n = 12), perception that insulin indicated end stage of diabetes (n = 11), inconvenience (n = 10), difficulty in insulin administration (n = 7), punishment (n = 7) and stigma and discrimination (n = 7). Healthcare professionals' barriers were as follows: poor knowledge and skills (n = 9), physician inertia (n = 5) and language barriers (n = 4). System barriers included lack of time (n = 5). The most common facilitators were understanding the benefits of insulin (n = 7), not being afraid of injections (n = 5), and patient education and information (n = 5). CONCLUSION: Major barriers to insulin initiation persist despite availability of newer and safer insulin. Healthcare professionals should explore and address these barriers. Targeted interventions should be developed to overcome these barriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields
Kmet, L. M., Cook, L. S., & Lee, R. C. (2004) · University of Alberta Library · doi:10.7939/r37m04f16 · Cited by 1,682
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881
Rosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-007-0911-x · Cited by 447
Long-Acting Glucagon-Like Peptide 1 Receptor Agonists
Garber, A. J. (2011) · Diabetes Care · doi:10.2337/dc11-s231 · Cited by 350
Cited by
Stigma in health facilities: Why it matters and how we can change it
Nyblade, L., Stockton, M. A., Giger, K., Bond, V., Ekstrand, M. L., Lean, R. M., Mitchell, E. M. H., Nelson, L. R. E., Sapag, J. C., Siraprapasiri, T., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1256-2 · Cited by 881
Niño de Guzmán Quispe, E., Martínez García, L., Orrego Villagrán, C., Heijmans, M., Sunol, R., Fraile-Navarro, D., Pérez-Bracchiglione, J., Ninov, L., Salas-Gama, K., Viteri García, A., et al. (2021) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-021-00514-2 · Cited by 54
“Weight Control For some patients with T2DM, weight control was ranked as very important, as measured in willingness-to-pay or discrete-choice exercises [105, 129], and was a concern when starting insulin therapy [131, 133].”
BackgroundLin, J., Zhou, S., Wei, W., Pan, C., Lingohr-Smith, M., & Levin, P. (2016) · Endocrine Practice · doi:10.4158/ep15868.or · Cited by 52
McGloin, H., O'Connell, D., Glacken, M., Mc Sharry, P., Healy, D., Winters-O'Donnell, L., Crerand, K., Gavaghan, A., & Doherty, L. (2020) · Journal of Medical Internet Research · doi:10.2196/16161 · Cited by 43
Metadata
- Authors
- Ng, C. J., Lai, P. S. M., Lee, Y. K., Azmi, S. A., & Teo, C. H.
- Venue
- International Journal of Clinical Practice
- Publisher
- Hindawi Limited
- Published
- 2015-07-06
- Volume
- 69
- Issue
- 10
- Pages
- 1050-1070
- ISSN
- 1368-5031 (ISSN-L)
- OpenAlex
- W1532059078
- Cited by
- 120
- References
- 4
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.